scanX
Home
Cipla

Cipla

1,467.50
-4.05
(-0.28%)
Market Cap (₹ Cr.)
₹1,18,826
52 Week High
1,702.05
Book Value
₹331
52 Week Low
1,164.55
PE Ratio
25.74
PB Ratio
4.19
PE for Sector
37.21
PB for Sector
3.95
ROE
15.50 %
ROCE
21.08 %
Dividend Yield
0.88 %
EPS
₹55.04
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
14.17 %
Net Income Growth
46.55 %
Cash Flow Change
27.68 %
ROE
29.66 %
ROCE
32.64 %
EBITDA Margin (Avg.)
12.02 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
2,742
3,641
3,109
2,782
2,843
2,822
2,847
2,720
2,716
2,735
3,246
3,011
2,788
3,094
3,395
2,912
3,551
3,323
3,683
2,999
3,547
3,174
3,847
3,828
2,694
4,097
4,038
3,981
4,065
3,993
4,259
3,744
3,751
4,476
4,554
4,647
4,632
4,715
5,064
Expenses
2,308
2,588
2,399
2,381
2,674
2,370
2,362
2,143
2,503
2,267
2,390
2,291
2,380
2,431
2,523
2,349
2,569
2,192
2,602
2,489
2,669
2,183
2,677
2,735
2,012
2,872
2,863
2,877
3,109
2,853
3,090
2,707
3,040
3,114
3,009
3,025
3,209
3,141
3,337
EBITDA
434
1,053
710
401
169
452
485
577
213
468
856
720
409
663
872
563
982
1,131
1,081
510
878
990
1,170
1,092
681
1,225
1,175
1,105
955
1,140
1,168
1,037
710
1,363
1,545
1,621
1,423
1,573
1,727
Operating Profit %
11 %
25 %
20 %
10 %
2 %
12 %
14 %
17 %
4 %
13 %
20 %
21 %
6 %
16 %
17 %
15 %
22 %
30 %
19 %
12 %
12 %
28 %
28 %
26 %
22 %
27 %
24 %
24 %
14 %
24 %
18 %
15 %
4 %
19 %
19 %
20 %
7 %
16 %
16 %
Depreciation
111
105
107
111
119
111
129
135
125
126
133
138
133
135
141
149
145
145
151
143
160
144
141
135
118
137
139
134
137
128
176
130
162
136
180
135
137
138
146
Interest
36
47
49
22
29
13
7
15
4
1
5
2
4
2
8
3
4
7
10
10
9
14
12
10
9
8
8
6
6
2
8
6
9
0
7
9
5
5
3
Profit Before Tax
287
901
553
269
21
328
349
426
84
341
718
581
272
525
723
412
833
978
920
358
709
832
1,018
947
555
1,080
1,028
965
813
1,010
985
901
540
1,226
1,358
1,477
1,281
1,430
1,578
Tax
73
207
21
42
11
35
59
126
91
71
140
157
63
113
131
108
224
257
144
61
84
238
282
252
132
303
243
250
160
259
265
215
223
340
330
349
240
358
407
Net Profit
214
695
532
226
9
279
329
341
26
259
566
419
225
391
568
295
634
694
737
282
605
610
746
699
413
792
782
731
653
759
720
679
355
895
1,030
1,114
1,038
1,056
1,178
EPS in ₹
2.66
8.65
6.63
2.82
0.11
3.47
4.10
4.25
0.32
3.22
7.03
5.20
2.79
4.85
7.06
3.67
7.87
8.61
9.15
3.50
7.50
7.57
9.25
8.67
5.13
9.82
9.70
9.06
8.09
9.41
8.93
9.41
4.40
11.09
14.17
14.99
12.86
13.08
14.59
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
15,192
15,239
15,607
17,095
18,419
20,406
22,964
25,449
27,597
31,053
Fixed Assets
3,594
3,826
4,236
4,320
4,189
4,151
4,066
3,910
3,809
3,719
Current Assets
6,559
6,467
6,345
7,938
9,479
9,027
10,192
11,335
13,371
14,858
Capital Work in Progress
361
551
556
463
297
320
355
268
504
670
Investments
384
4,256
4,286
4,637
5,815
7,190
9,726
10,974
11,909
13,794
Other Assets
10,853
6,606
6,530
7,675
8,117
8,745
8,816
10,298
11,374
12,871
Total Liabilities
4,102
3,253
2,807
2,982
2,637
3,003
3,036
2,936
2,958
3,079
Current Liabilities
3,566
2,954
2,556
2,732
2,368
2,619
2,692
2,659
2,700
2,862
Non Current Liabilities
535
299
251
250
269
383
344
276
259
217
Total Equity
11,090
11,986
12,801
14,114
15,782
17,403
19,928
22,514
24,638
27,974
Reserve & Surplus
10,930
11,825
12,640
13,953
15,621
17,242
19,766
22,352
24,477
27,812
Share Capital
161
161
161
161
161
161
161
161
161
161
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
37
-25
5
173
-153
197
33
-117
-148
135
Investing Activities
-1,194
-1,206
-1,192
-593
-1,148
-1,127
-3,361
-2,464
-2,758
-2,883
Operating Activities
1,051
1,728
2,207
1,117
1,468
2,018
3,460
2,773
3,035
3,727
Financing Activities
180
-547
-1,011
-351
-473
-694
-66
-427
-425
-709
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
36.73 %
36.72 %
36.12 %
36.11 %
33.63 %
33.61 %
33.61 %
33.61 %
33.55 %
33.47 %
33.47 %
33.47 %
33.47 %
30.91 %
30.92 %
FIIs
23.25 %
24.82 %
24.79 %
24.35 %
26.64 %
27.64 %
27.68 %
28.38 %
27.41 %
25.49 %
25.74 %
25.73 %
25.83 %
27.81 %
28.80 %
DIIs
17.18 %
16.26 %
21.04 %
21.53 %
22.01 %
21.34 %
21.73 %
21.14 %
22.10 %
24.34 %
24.18 %
24.34 %
24.42 %
24.95 %
24.17 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
22.84 %
22.21 %
18.05 %
18.01 %
17.73 %
17.40 %
16.97 %
16.87 %
16.94 %
16.70 %
16.60 %
16.46 %
16.28 %
16.33 %
16.11 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,773.90 4,25,929.94 38.00 49,887.17 12.06 9,648 27.35 40.28
Cipla
1,462.55 1,18,825.56 25.74 26,520.66 14.17 4,155 12.95 38.47
Mankind Pharma
2,530.10 1,02,885.42 48.65 10,615.63 19.57 1,942 28.89 46.80
Dr Reddys Laboratories
1,194.85 1,01,290.13 18.97 28,905.40 12.36 5,578 -9.47 32.64
Zydus Life Science
942.20 95,280.30 22.27 19,831.50 13.82 3,831 14.57 32.02
Lupin
2,050.65 92,929.19 35.38 20,141.50 19.94 1,936 73.52 37.01
Aurobindo Pharma
1,228.60 73,119.28 20.05 29,559.25 17.55 3,169 8.65 20.74
Alkem Laboratories
5,614.65 66,062.65 30.38 12,978.42 9.84 1,811 14.16 35.74
Glenmark Pharmaceuticals
1,473.60 42,112.35 - 12,653.09 6.58 -1,831 675.84 30.08
IPCA Laboratories
1,578.85 39,910.21 59.43 7,829.81 22.92 529 80.05 52.38

Corporate Action

Technical Indicators

RSI(14)
Neutral
38.47
ATR(14)
Less Volatile
41.31
STOCH(9,6)
Neutral
25.67
STOCH RSI(14)
Neutral
48.14
MACD(12,26)
Bearish
-5.31
ADX(14)
Weak Trend
23.07
UO(9)
Bearish
36.03
ROC(12)
Uptrend And Accelerating
3.76
WillR(14)
Neutral
-67.26
Bearish
4
Neutral
4
Bullish
1
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Intraday Screeners
Price & Volume Screeners
Technical Screeners
Candlestick Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.